Meeting
2020 Gastrointestinal Cancers Symposium
Personalized ANtibodies for GastroEsophageal Adenocarcinoma (PANGEA): Primary efficacy analysis of the phase II platform trial (NCT02213289).
Authors
Daniel V.T. Catenacci
University of Chicago Medical Center and Biological Sciences, Chicago, IL
Daniel V.T. Catenacci , Samantha Lomnicki , Leah Chase , Bryan Peterson , Kelly Moore , Ugne Markevicius , Lindsay Alpert , Namrata Setia , John Hart , Chih-Yi Liao , Uzma Siddiqui , Kiran Turaga , Mitchell C. Posner , Kristen Kipping-Johnson , Sunil Narula , Murtuza M. Rampurwala , Yuan Ji , Theodore Karrison , Blase N. Polite , Hedy L. Kindler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT02213289
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 356)
Abstract #
356
Poster Bd #
D11
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Final analysis of a phase II trial.
First Author: Haeseong Park
Poster
2021 ASCO Annual Meeting
Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.
First Author: Hongli Li
Poster
2021 Gastrointestinal Cancers Symposium
Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma.
First Author: Ning Li
Poster
2020 ASCO Virtual Scientific Program
Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): Secondary and final primary efficacy analyses.
First Author: Daniel V.T. Catenacci